STAT3 and ovarian carcinoma: In addition to the in vitro studies, we also demonstrate that paclitaxel treatment significantly enhanced the activation of the JAK2/STAT3 pathway and CSC-like phenotype in the xenografts of mice injected with a serous human ovarian cancer HEY cell line.